Publication | Closed Access
Gemigliptin, a novel dipeptidyl peptidase-4 inhibitor, exhibits potent anti-glycation properties in vitro and in vivo
19
Citations
17
References
2014
Year
Medicinal ChemistryBiochemistryMedicineNatural SciencesPeptoidGlycobiologyPotent Anti-glycation PropertiesPharmacologyCarbohydrate-protein InteractionDrug DiscoveryGlycosylation
| Year | Citations | |
|---|---|---|
Page 1
Page 1